Injective ETF Gains Nasdaq Listing Approval as INJ Price Eyes Recovery

Injective is gaining institutional attention after Canary Capital's Staked INJ ETF secured Nasdaq listing approval, expanding traditional investment access to the ecosystem. Meanwhile, INJ has broken above $7.30, strengthening its short-term bullish structure, with traders watching $7.55 and the $8.00–$8.20 range for further upside.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TronWeekly.